Xenetic Biosciences, Inc. 4
4 · Xenetic Biosciences, Inc. · Filed Apr 4, 2017
Insider Transaction Report
Form 4
PARSLOW JAMES F
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2017-04-03+175,000→ 175,000 totalExercise: $4.57Exp: 2027-04-03→ Common Stock (175,000 underlying)
Footnotes (1)
- [F1]The shares underlying the option will vest and become exercisable over three years, with one-third of the underlying shares vesting on each of April 3, 2018, April 3, 2019 and April 3, 2020, subject to the Reporting Person's continuous service with the Issuer through each such date.